Georg Massler-Karpel

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Journal: Acta neuropathologica communications
Published: June 02, 2026

Assessment of Photodynamic Therapy Penetration Depth in a Synthetic Pig Brain Model: A Novel Approach to Simulate the Reach of PDT-Mediated Effects In Vitro.

Assessment of Photodynamic Therapy Penetration Depth in a Synthetic Pig Brain Model: A Novel Approach to Simulate the Reach of PDT-Mediated Effects In Vitro.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 12, 2025

CDK12 regulates cellular metabolism to promote glioblastoma growth.

CDK12 regulates cellular metabolism to promote glioblastoma growth.

Journal: JCI insight
Published: January 02, 2025

Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen.

Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen.

Journal: Brain sciences
Published: October 14, 2024

Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma.

Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma.

Journal: Cells
Published: June 05, 2024

Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma.

Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma.

Journal: Photodiagnosis and photodynamic therapy
Published: January 08, 2024

The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours.

The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours.

Journal: Molecular oncology
Published: October 17, 2023

Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.

Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.

Journal: British journal of cancer
Published: June 18, 2023

OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.

OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.

Journal: JCI insight
Published: May 24, 2023

Targeting cellular respiration as a therapeutic strategy in glioblastoma.

Targeting cellular respiration as a therapeutic strategy in glioblastoma.

Journal: Oncotarget
Published: May 04, 2023

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.

Journal: Cells
Published: August 26, 2022

Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure.

Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure.

Journal: Expert opinion on drug discovery
Published: August 23, 2022
Showing 1-12 of 100

Last Updated: 09/26/2026